Comparison

Recombinant Human PD-L1/B7-H1/CD274 Protein (His Tag)

Item no. ELS-PKSH033557-10ug
Manufacturer Elabscience
Amount 10 ug
Quantity options 10 ug 50 ug
Category
Type Proteins
Format Lyophilized Powder
Applications ELISA
Specific against Human (Homo sapiens)
Host HEK293 cells
Conjugate/Tag HIS
Purity > 95 % as determined by reducing SDS-PAGE.
Sequence Phe19-Thr239
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias B7 Homolog 1, B7-H1, B7H1, CD274, PD-L1, PDCD1 Ligand 1, PDCD1L1, PDCD1LG1, PDL1, Programmed Cell Death 1 Ligand 1, Programmed Death Ligand 1
Similar products CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1, PD-L1, B7-H1, Programmed Cell Death 1 Ligand 1, PDCD1 Ligand 1, Programmed Death Ligand 1, B7 Homolog 1
Shipping Condition Cool pack
Available
Manufacturer - Category
Recombinant Proteins / Immune Checkpoint Proteins
Manufacturer - Conjugate / Tag
C-His
Shipping Temperature
This product is provided as lyophilized powder which is shipped with ice packs.
Storage Conditions
Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Calculated Molecular Weight
26.3 kDa
Observed Molecular Weight
34-42 kDa
Research Areas
Cancer, immunology
Background
CD274; also known as B7-H1 or programmed death ligand 1 (PD-L1); is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. Programmed death-1 ligand-1 (PD-L1; CD274; B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. By binding to PD1 on activated T-cells and B-cells; PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly; it leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. PD-L1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers.
Abbreviation
PD-L1; B7-H1; CD274
Endotoxin
< 1.0 EU per μg of the protein as determined by the LAL method.
Reconstitution
Please refer to the printed manual for detailed information.
Formulation
Lyophilized from a 0.2 μm filtered solution of 20mM PB, 4% Mannitol, 0.02% Tween 80, pH7.4.
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Activity
Immobilized Anti-Human PDL1 mAb at 2μg/ml (100 μl/well)can bind Human PD-L1-His.The ED50 of Human PD-L1-6His is 5.57 ng/ml.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?